IFP Advisors
IMNM icon

IFP Advisors’s Immunome IMNM Stock Holding History

IFP Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$129 Hold
6
– – ﹤0.01% 4946
2026
Q2 		$127 Hold
6
– – ﹤0.01% 4930
2026
Q1 		$131 Hold
6
– – ﹤0.01% 4698
2025
Q4 		$129 Hold
6
– – ﹤0.01% 4550
2025
Q3 		$70 Hold
6
– – ﹤0.01% 4602
2025
Q2 		$56 Buy
+6
New +$49 ﹤0.01% 4788
2025
Q1 		– Hold
0
– – – 3737
2024
Q4 		– Hold
0
– – – 3640

Other funds holding IMNM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

IFP Advisors's IMNM Position: Q3 2026 in Review

IFP Advisors held its Immunome (IMNM) position steady in Q3 2026 at 6 shares worth $129. The position accounts for ﹤0.01% of the portfolio, ranked #4946.

IFP Advisors first reported a position in IMNM in Q2 2025 and has held it in 6 quarters since. The position peaked at $131 in Q1 2026. 65 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

  • IFP Advisors held 6 shares of Immunome worth $129 as of Q3 2026.
  • IFP Advisors left its Immunome share count unchanged in Q3 2026.
  • Immunome made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4946 holding.
  • IFP Advisors first reported a position in Immunome in Q2 2025 and has held it in 6 quarters since.
  • IFP Advisors's Immunome position peaked at $131 in Q1 2026.
  • 65 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.